Inovio Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
INO
CUSIP
45773H409
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 45773H409 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
10.3% 8/6/2026
Event 6/30/2026
Janus Henderson Group PLC 13G/A 10.0% 12/8/2025
Event 11/28/2025
RA Capital Management, L.P. 13G
9.9% 8/7/2026
Event 7/31/2026
Highbridge Capital Management LLC 13G/A 8.2% 5/15/2026
Event 3/31/2026
Alyeska Investment Group, L.P. 13G/A
6.0% 2/17/2026
Event 12/31/2025
Vanguard Capital Management LLC 13G 5.1% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Vanguard Group Inc 13G/A 4.96% 1/30/2026
Event 12/31/2025
Adage Capital Management, L.P. 13G/A
4.0% 8/12/2026
Event 6/30/2026
Stonepine Capital Management, LLC 13G/A
3.8% 5/14/2025
Event 3/31/2025
Deep Track Capital, LP 13G/A
2.4% 11/14/2025
Event 9/30/2025
BlackRock, Inc. 13G/A 1.5% 7/17/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 115 k $140 k
2026 Q2 111 32.8 M $36.1 M
2026 Q1 107 31.4 M $54.6 M
2025 Q4 110 33.1 M $57.5 M
2025 Q3 106 20.8 M $48.6 M
2025 Q2 111 10.3 M $20.9 M
2025 Q1 112 13.6 M $22.2 M
2024 Q4 113 13.4 M $24.5 M
2024 Q3 107 8.58 M $49.5 M
2024 Q2 106 8.17 M $66.0 M
2024 Q1 96 4.20 M $58.2 M
2023 Q4 7 299 k $153 k